Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
A phase 2 trial of Leuprolide, Degarelix, Relugolix, Triptorelin, Bicalutamide and Flotufolastat F-18 in Prostate cancer, run by Baptist Health South Florida, now recruiting.
Overview
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT is a phase 2 interventional study registered as NCT07455903 by Baptist Health South Florida, with 50 participants planned, started 2026-07-29 and due to reach its primary completion in 2030-02. Interventions recorded: Leuprolide, Degarelix, Relugolix, Triptorelin, Bicalutamide, 18-F Flotufolastat PSMA PET, Radical prostatectomy. Conditions recorded: Prostate Cancer, Localized Prostate Carcinoma.
Linked to the drug Flotufolastat F-18 because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Shares Relugolix, Degarelix, Triptorelin, Leuprolide (leuprorelin) and GnRH agonists and the tag pipeline.
- TrialTwo Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Shares Relugolix, Degarelix, Triptorelin, Bicalutamide and the tag pipeline.
- TrialRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Shares Degarelix, Triptorelin, Bicalutamide, Prostate cancer and the tag pipeline.
- TrialStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Shares Degarelix, Triptorelin, Bicalutamide, Leuprolide (leuprorelin) and GnRH agonists and the tag pipeline.
- TrialPET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
Shares Flotufolastat F-18, Prostate cancer and the tag pipeline.
- TrialDiagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Shares Flotufolastat F-18, Prostate cancer and the tag pipeline.
- TrialNeoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Shares Degarelix, Bicalutamide, Prostate cancer and the tag pipeline.
- TrialInvestigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients
Shares Degarelix, Bicalutamide, Prostate cancer and the tag pipeline.